CHNA
Loncar China BioPharma ETF
CHNA
CHNA
Delisted
CHNA was delisted on the 20th of October, 2023.
2 hedge funds and large institutions have $314K invested in Loncar China BioPharma ETF in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$270K |
Top Sellers
| 1 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$15K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| $270K | +$270K | +12,166 | New |
|
2
Morgan Stanley
New York
| $44K | – | – | – |
|
|
3
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$15K | -652 | Closed |
|